Stock listing

Lir Life Sciences Corp.

Selected listing: N790 · SWB · EUR · DE

Lir Life Sciences Corp. (Stuttgart:N790), Non-Energy Minerals. Latest release Jul 16, 2026: LIR Life Sciences Signs Development Services Agreement with Oxygen…

N790:SWBEURDEUpdated October 3, 2026

Ticker: Stuttgart:N790
Asset type: Stock
Sector: Non-Energy Minerals
Industry: Other Metals/Minerals
Exchange: Stuttgart
Currency: EUR

About Lir Life Sciences Corp.

The company focuses on developing innovative solutions in the life sciences sector. Lir Life Sciences aims to advance healthcare through its research and product offerings.

Latest news from Lir Life Sciences Corp.

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

July 16, 2026

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide

June 17, 2026

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

May 22, 2026

LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules

April 28, 2026

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.

April 20, 2026

All Lir Life Sciences Corp. news →

Research Lir Life Sciences Corp.

Lir Life Sciences Corp. company profile

View the public company page for Lir Life Sciences Corp. on 6ix.

Lir Life Sciences Corp. news

Read company news and market updates connected to Lir Life Sciences Corp..

Lir Life Sciences Corp. investor events

Find investor webinars, events, and replay context for Lir Life Sciences Corp..